The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
Open accessAbstract
We characterized the binding of [125I]epidepride to dopamine D2-like and D3-like receptors in tissue sections of human striatum. The competition for binding of [125I]epidepride by domperidone, quinpirole, and 7-hydroxy-N,N-di(1-propyl)-2-aminotetralin (7-OH-DPAT) was best fit by assuming one site in the caudate but two sites in nucleus accumbens. Guanosine 5'-[beta, gamma-imido]triphosphate showed a large modulatory influence in agonist inhibition of [125I]epidepride binding in caudate but not in nucleus accumbens. The binding of [125I]epidepride in the presence of 7-OH-DPAT (1000-fold selective for D3-like versus D2-like sites) and domperidone (20-fold selective for D2-like versus D3-like sites) was used to quantify the numbers of D2-like and D3-like receptors in areas of human brain. The distribution of D2-like and D3-like receptors was largely nonoverlapping. Binding of [125I]epidepride to D3-like receptors was negligible in the dorsal striatum but was concentrated in islands of dense binding in the nucleus accumbens and ventral putamen that aligned with acetylcholinesterase-poor striosomes. Binding to D3-like receptors was also enriched in the internal globus pallidus, ventral pallidum, septum, islands of Calleja, nucleus basalis, amygdalostriatal transition nucleus of the amygdala, central nucleus of the amygdala, and ventral tegmental area. Binding of [125I]epidepride to D2 but not D3 receptors was detected in cortex and hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674
Mansour, A., Meador-Woodruff, J., Bunzow, Jr., Civelli, O., Akil, H., & Watson, S. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02587.1990 · Cited by 467
Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain
McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E., & Nagai, T. (1984) · Neurology · doi:10.1212/wnl.34.6.741 · Cited by 457
Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M.-P., Giros, B., & Schwartz, J.-C. (1992) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(92)90107-7 · Cited by 400
Jimenez-Castellanos, J., & Graybiel, A. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90285-5 · Cited by 271
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio, C. L., Lajiness, M. E., & Huff, R. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09903-1 · Cited by 254
Molecular biology of the dopamine receptors
Civelli, O., Bunzow, J. R., Grandy, D. K., Zhou, Q.-Y., & Van Tol, H. H. M. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90001-x · Cited by 239
Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman, S. B., Patel, S., Marwood, R., Emms, F., Seabrook, G. R., Knowles, M. R., & McAllister, G. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38490-9 · Cited by 223
Cited by
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
Tziortzi, A. C., Searle, G. E., Tzimopoulou, S., Salinas, C., Beaver, J. D., Jenkinson, M., Laruelle, M., Rabiner, E. A., & Gunn, R. N. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.044 · Cited by 452
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Self-citationThe involvement of dopamine in the modulation of sleep and waking
Monti, J. M., & Monti, D. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.08.003 · Cited by 415
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385
Metadata
- Authors
- Murray, A. M., Ryoo, H. L., Gurevich, E., & Joyce, J. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-11-08
- Volume
- 91
- Issue
- 23
- Pages
- 11271-11275
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1967823110
- Cited by
- 325
- References
- 20
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. https://app.cochat.ai/papers/10.1073/pnas.91.23.11271
- The paper
- Murray, A. M., Ryoo, H. L., Gurevich, E., & Joyce, J. N. (1994). Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.91.23.11271
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.